TipRanks
Advertisement
Advertisement

HK:1011 Stock Latest News

China NT Pharma Pursues Court Enforcement in Shareholder Information Dispute Over Kangchen Biological
Company AnnouncementsChina NT Pharma Pursues Court Enforcement in Shareholder Information Dispute Over Kangchen Biological
7d ago
1011
China NT Pharma Faces RMB75 Million Arbitration Award Over Miacalcic Deal
PremiumCompany Announcements
China NT Pharma Faces RMB75 Million Arbitration Award Over Miacalcic Deal
7d ago
1011
China NT Pharma Names HLB as New Auditor After Shareholder Rebuff
PremiumCompany Announcements
China NT Pharma Names HLB as New Auditor After Shareholder Rebuff
18d ago
1011
China NT Pharma Completes Loan Capitalisation Via Major Share Subscription
PremiumCompany Announcements
China NT Pharma Completes Loan Capitalisation Via Major Share Subscription
28d ago
1011
China NT Pharma Overhauls Key Company Secretary and Compliance Roles
PremiumCompany Announcements
China NT Pharma Overhauls Key Company Secretary and Compliance Roles
1M ago
1011
China NT Pharma Wins Share Issue Mandate but Loses Auditor Vote at EGM
PremiumCompany AnnouncementsChina NT Pharma Wins Share Issue Mandate but Loses Auditor Vote at EGM
1M ago
1011
NT Pharma Revenue Nearly Doubles but Interim Losses Persist
Premium
Company Announcements
NT Pharma Revenue Nearly Doubles but Interim Losses Persist
1M ago
1011
China NT Pharma Faces RMB92 Million Arbitration Award Over 2020 Asset Deal
Premium
Company Announcements
China NT Pharma Faces RMB92 Million Arbitration Award Over 2020 Asset Deal
2M ago
1011
China NT Pharma Seeks Shareholder Approval for Major Debt-to-Equity Share Subscriptions
PremiumCompany Announcements
China NT Pharma Seeks Shareholder Approval for Major Debt-to-Equity Share Subscriptions
2M ago
1011
China NT Pharma Schedules Board Meeting to Review Interim Results and Dividend
PremiumCompany Announcements
China NT Pharma Schedules Board Meeting to Review Interim Results and Dividend
2M ago
1011
China NT Pharma Advances Medical Device Integration and Debt Restructuring
PremiumCompany Announcements
China NT Pharma Advances Medical Device Integration and Debt Restructuring
2M ago
1011
China NT Pharma Further Delays Circular on Loan Capitalisation Plan
PremiumCompany Announcements
China NT Pharma Further Delays Circular on Loan Capitalisation Plan
2M ago
1011
China NT Pharma Delays Shareholder Circular on Loan Capitalisation
PremiumCompany AnnouncementsChina NT Pharma Delays Shareholder Circular on Loan Capitalisation
3M ago
1011
China NT Pharma Proposes New Auditor CCTH CPA After Moore’s Retirement
Premium
Company Announcements
China NT Pharma Proposes New Auditor CCTH CPA After Moore’s Retirement
3M ago
1011
China NT Pharma Names New CEO as Leadership Shifts to Next Generation
Premium
Company Announcements
China NT Pharma Names New CEO as Leadership Shifts to Next Generation
3M ago
1011
China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions
PremiumCompany Announcements
China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions
3M ago
1011
China NT Pharma to Capitalise Debts via Major Share Issue to Connected Creditors
PremiumCompany Announcements
China NT Pharma to Capitalise Debts via Major Share Issue to Connected Creditors
4M ago
1011
China NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
PremiumCompany Announcements
China NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
4M ago
1011
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
PremiumCompany Announcements
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
4M ago
1011
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
PremiumCompany AnnouncementsChina NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
4M ago
1011
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
Premium
Company Announcements
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
5M ago
1011
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
Premium
Company Announcements
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
5M ago
1011

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >